Ameriprise Financial »

Rapport Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.7M 125k 29.70

More positions owned by Ameriprise Financial

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Facebook Inc cl a (META)
iShares S&P 500 Index (IVV)
Visa (V)
Lam Research (LRCX)
Bank of America Corporation (BAC)
Alphabet Inc Class C cs (GOOG)
Wal-Mart Stores (WMT)
Vanguard S&p 500 Etf idx (VOO)

View all positions for Ameriprise Financial

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics